H Røsjø

First name:
H
Last name:
Røsjø
Røsjø, H., Husberg, C., Dahl, M. B., Stridsberg, M., Sjaastad, I., Finsen, A. V., et al. (2010). Chromogranin B in heart failure: a putative cardiac biomarker expressed in the failing myocardium. Circulation. Heart Failure, 3(4), 503-11. https://doi.org/10.1161/CIRCHEARTFAILURE.109.867747
View
Ottesen, A. H., Louch, W. E., Carlson, C. R., Landsverk, O. J. B., Kurola, J., Johansen, R. F., et al. (2015). Secretoneurin is a novel prognostic cardiovascular biomarker associated with cardiomyocyte calcium handling. Journal Of The American College Of Cardiology, 65(4), 339-351. https://doi.org/10.1016/j.jacc.2014.10.065 (Original work published 2015)
View
Ottesen, A. H., Carlson, C. R., Louch, W. E., Dahl, M. B., Sandbu, R. A., Johansen, R. F., et al. (2017). Glycosylated Chromogranin A in Heart Failure: Implications for Processing and Cardiomyocyte Calcium Homeostasis. Circulation. Heart Failure, 10(2). https://doi.org/10.1161/CIRCHEARTFAILURE.116.003675
View
Brynildsen, J., Petäjä, L., Nygård, S., Vaara, S. T., Linko, R., Okkonen, M., et al. (2018). The predictive value of NT-proBNP and hs-TnT for risk of death in cardiac surgical patients. Clinical Biochemistry. https://doi.org/10.1016/j.clinbiochem.2018.01.012 (Original work published 2018)
View
Ottesen, A. H., Carlson, C. R., Eken, O. S., Sadredini, M., Myhre, P. L., Shen, X., et al. (2019). Secretoneurin Is an Endogenous Calcium/Calmodulin-Dependent Protein Kinase II Inhibitor That Attenuates Ca2+-Dependent Arrhythmia.. Circulation. Arrhythmia And Electrophysiology, 12(4), e007045. https://doi.org/10.1161/CIRCEP.118.007045
View